Elan/O'Brien Pharmaceuticals
Executive Summary
Elan is purchasing a 27% interest in the Parsippany, N.J.-based O'Brien in an agreement that will allow Elan to increase its total equity to approximately 60%. Elan said that under the agreement it will become the marketing partner of Roussel-Uclaff and both Elan and O'Brien will market Roussel's Reabilan and Reabilan HN enteral nutrition products under the Elan Pharma/Roussel name.